1-[(6-chloropyridin-3-yl)methyl]-N-[3-[3-[4-[(dimethylamino)methyl]phenyl]-1H-indazol-6-yl]prop-2-enyl]-2-oxopyridine-3-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-[(6-chloropyridin-3-yl)methyl]-N-[3-[3-[4-[(dimethylamino)methyl]phenyl]-1H-indazol-6-yl]prop-2-enyl]-2-oxopyridine-3-carboxamide
• 化学式: C₃₁H₂₉ClN₆O₂
• 分子量: 553.1
• InChiKey: BIUNNPGJIJLQJK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  40
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  94.2
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• PYRIDONS AS PDK1 INHIBITORS
  申请人：Engelhardt Harald

  公开号：US20110269958A1

  公开（公告）日：2011-11-03

  The present invention encompasses compounds of general formula (1) while the groups R 4 to R 7 and the units W, L, Q a and Q H are defined as in claim 1 , which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.

  本发明涵盖了一般式（1）的化合物，其中R4到R7和单位W、L、Qa和QH的定义如权利要求1所述，适用于治疗由过度或异常细胞增殖特征的疾病，并且它们作为具有上述特性的药物的用途。
• JP2011528026A
  申请人：——

  公开号：JP2011528026A

  公开（公告）日：2011-11-10
• US8637549B2
  申请人：——

  公开号：US8637549B2

  公开（公告）日：2014-01-28
• [EN] NEW CHEMICAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS CHIMIQUES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2010007116A2

  公开（公告）日：2010-01-21

  The present invention encompasses compounds of general formula (1) while the groups R4 to R7 and the units W, L, Qa and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.